Suchergebnisse - "Yoshimura, Akihiro"

PubPharm (4)

1

High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib

enthalten in: Cancer science | 2023

von Yoshimura, A. | Yamada, T. | Serizawa, M. | +25

2

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

enthalten in: Nature communications | 2020

von Wang, R. | Yamada, T. | Kita, K. | +24

3

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Okura, N. | Nishioka, N. | Yamada, T. | +19

4

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

enthalten in: Nature communications | 2019

von Taniguchi, H. | Yamada, T. | Wang, R. | +21

1
[1]